Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: Effects on steroidogenesis and oncogenesis
Abstract
We describe a mechanism of gene regulation involving formation of a complex between PSF protein and mouse VL30 (mVL30) retrotransposon RNA. PSF represses transcription of the insulin-like growth factor 1 (IGF1)-inducible gene P450scc by binding to an insulin-like growth factor response element (IGFRE) motif in the gene. The complex with mVL30 RNA releases PSF, allowing transcription to proceed. Retrovirally mediated transmission of mVL30 RNA to human tumor cells induced several genes, including oncogenes, which also are induced by IGF1, and promoted metastasis. In mice, steroid synthesis is activated in steroidogenic cells by pituitary hormones, which concomitantly induce transcription of mVL30 RNA in the cells. We showed that steroid synthesis could also be activated in mouse steroidogenic adrenal cells by transfection with cDNA encoding either mVL30 RNA tracts that form a complex with PSF or a small interfering RNA (siRNA) that degrades PSF transcripts. These results suggest that mVL30 RNA regulates steroidogenesis, and possibly other physiological processes of mice, by complex formation with PSF. Retrotransposons such as mVL30 apparently evolved not only as “junk” DNA but also as transcriptionally active noncoding DNA that acquired physiological and pathological functions.
Acknowledgments
We thank Dr. James Patton for providing the anti-PSF antibody, Dr. Randall Urban for providing an expression plasmid encoding the PSF protein, and Dr. Cecilia Guerrier-Takada for providing the plasmid pmU6(-315/1)pBSKAmp. The research reported here was supported in part by Program Project Grant HL29019 from the National Institutes of Health and by generous gifts from private donors.
References
1
French, N. S. & Norton, J. D. (1997) Biochim. Biophys. Acta 1352, 33–47.
2
Song, X., Wang, B., Bromberg, M., Hu, Z., Konigsberg, W. & Garen A. (2002) Proc. Natl. Acad. Sci. USA 99, 6269–6273.
3
Patton, J. G., Porro, E. B., Galceran, J., Tempst, P. & Nadal-Ginard, B. (1993) Genes Dev. 7, 393–406.
4
Peng, R., Dye, B. T., Perez, I., Barnard, D. C., Thompson, A. B. & Patton, J. G. (2002) RNA 8, 1334–1347.
5
Urban, R. J., Bodenburg, Y., Kurosky, A., Wood, T. G. & Gasic, S. (2000) Mol. Endocrinol. 14, 774–782.
6
Shav-Tal, Y. & Zipori, D. (2002) FEBS Lett. 531, 109–114.
7
Das, G., Henning, D., Wright, D. & Reddy, R. (1988) EMBO J. 7, 503–512.
8
Gou, D., Jin, N. & Liu, L. (2003) FEBS Lett. 548, 113–118.
9
Waterman, M. R., Mason, J. I. & Simpson, E. R. (1988) Prog. Clin. Biol. Res. 274, 543–555.
10
Stocco, D. M. & Clark, B. J. (1996) Endocr. Rev. 17, 221–244.
11
Yasumura, Y., Buonassisi, V. & Sato, G. (1966) Cancer Res. 26, 529–535.
12
Schiff, R., Itin, A. & Keshet, E. (1991) Genes Dev. 5, 521–532.
13
Bohm, S., Bakke, M., Nilsson, M., Zanger, U. M., Spyrou, G. & Lund, J. (1993) J. Biol. Chem. 268, 3952–3963.
14
Carlock, L., Vo, T., Lorincz, M., Walker, P. D., Bessert, D., Wisniewski, D. & Dunbar, J. C. (1996) Brain Res. Mol. Brain 42, 202–212.
15
Sertie, A. L., Sossi, V., Camargo, A. A., Zatz, M., Brahe, C. & Passos-Bueno, M. R. (2000) Hum. Mol. Genet. 9, 2051–2058.
16
Mozer, B. A. & Benzer, S. (1994) Development 120, 1049–1058.
17
Furstenberger, G. & Senn, H. J. (2002) Lancet Oncol. 3, 298–302.
18
Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S. & Boon, T. (1995) J. Exp. Med. 182, 689–698.
19
Stoesz, S. P., Friedl, A., Haag, J. D., Lindstrom, M. J., Clark, G. M. & Gould, M. N. (1998) Int. J. Cancer 79, 565–572.
20
Easty, D. J., Mitchell, P. J., Patel, K., Florenes, V. A., Spritz, R. A. & Bennett, D. C. (1997) Int. J. Cancer 71, 1061–1065.
21
Shav-Tal, Y., Cohen, M., Lapter, S., Dye, B., Patton, J. G., Vandekerckhove, J. & Zipori, D. (2001) Mol. Biol. Cell 12, 2328–2340.
Information & Authors
Information
Published in
Classifications
Copyright
Copyright © 2004, The National Academy of Sciences.
Submission history
Published online: January 2, 2004
Published in issue: January 13, 2004
Acknowledgments
We thank Dr. James Patton for providing the anti-PSF antibody, Dr. Randall Urban for providing an expression plasmid encoding the PSF protein, and Dr. Cecilia Guerrier-Takada for providing the plasmid pmU6(-315/1)pBSKAmp. The research reported here was supported in part by Program Project Grant HL29019 from the National Institutes of Health and by generous gifts from private donors.
Authors
Metrics & Citations
Metrics
Citation statements
Altmetrics
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
Cited by
Loading...
View Options
View options
PDF format
Download this article as a PDF file
DOWNLOAD PDFLogin options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginRecommend to a librarian
Recommend PNAS to a LibrarianPurchase options
Purchase this article to access the full text.